Mycophenolatmofetil Accord (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Mycophenolatmofetil Accord, is an immunosuppressant (antimetabolite) presented as an oral tablet for oral use. It is used to prevent organ transplant rejection and to treat certain autoimmune kidney diseases. GNH USA supplies Mycophenolatmofetil Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mycophenolate Mofetil is employed in the management of immune‑mediated conditions where suppression of lymphocyte proliferation is required.

Kidney transplant: helps prevent acute and chronic rejection of the transplanted kidney. Heart transplant: reduces the risk of graft rejection and improves graft survival. Liver transplant: supports long‑term graft acceptance and lowers rejection episodes. Lupus nephritis: diminishes renal inflammation and preserves kidney function in patients with systemic lupus erythematosus.

Adverse reactions may occur with Mycophenolate Mofetil therapy.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Vomiting: occasional episodes. - Headache: transient mild pain. - Tremor: fine shaking of hands.

Serious or Rare Side Effects: - Opportunistic infections: increased susceptibility to viral, fungal, or bacterial infections. - Bone marrow suppression: leukopenia, anemia, or thrombocytopenia. - Hepatotoxicity: elevated liver enzymes or jaundice. - Malignancy: rare increased risk of certain cancers. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Progressive multifocal leukoencephalopathy (PML): rare but life‑threatening brain infection.

Patients receiving Mycophenolate Mofetil should be monitored closely for safety concerns.

Monitor blood counts: watch for leukopenia, anemia, or thrombocytopenia. Assess renal function: adjust dose if creatinine clearance declines. Check liver enzymes: detect early signs of hepatotoxicity. Avoid live vaccines: risk of uncontrolled infection. Use effective contraception: teratogenic potential is unknown. Store at below 25°C: keep in the original pack, protect from moisture.

Mycophenolate Mofetil can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Live vaccines: heightened infection risk. - Cholestyramine or colestipol: reduces drug absorption.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may increase risk of hyperkalemia. - NSAIDs: can worsen renal impairment. - Antacids (aluminum or magnesium): may lower bioavailability.